Healthcare waste in US is estimated to be around $750 Billion/year, which is enough to send every 17 and 18 year old in the US to a state university for four years*.More than half of this waste is caused by avoidable harm on patients, that is, preventable adverse outcomes.Unlike other predictive analytics companies that just provide risk on patients, Jvion provides risk, likelihoods of changing the outcome, and, individualized patient level interventions to reduce avoidable harm.To date, Jvion platform has touched more than 3 million patient lives at a large client base including many prestigious names. Today, top 12 of the top 20 hospitals are Jvion customers. This has been achieved in such a short time due to the phenomenal team as well as a unique machine that can address 50+ avoidable harm vectors (such as sepsis, HAC, HAI, readmissions, falls, and pressure wounds) without the need to create new models or need to have perfect data.Jvion has repeatedly made more on-the-ground impact while numbers large banner companies have failed at applying AI to a clinical setting. primary reason for this is that unlike traditional AI and analytics solutions that merely identify high-risk patients, the Jvion Machine pinpoints patients on a risk trajectory, determines if specific patients’ trajectories can be changed and if so, provides patient-specific interventions. This makes the solution actionable.Today, Jvion has more satisfied customers in clinical AI space than any other vendor in the country. We are the clear market leaders and are investing heavily to make sure we stay in that position.